ARCHIVES

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Halterman, Mahoney And Their Grants Go To DCT, Along With Some Program Projects

March 17, 1978

New Jersey Legislature Votes to Oppose USPSTF PSA Screening Downgrade

January 20, 2012

DeVita Appointment Now Official; Calls For New Chemoprevention Program, More Applied Prevention

July 18, 1980

Blacks At 11% Greater Cancer Risk, 27% Higher Mortality, NCI Tell President’s Cancer Panel

March 10, 1989

FDA Approves Molecular Test For Breast Cancer Detection

July 27, 2007

In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available

July 1, 1977